SARS-CoV2 related acute respiratory distress syndrome (ARDS) is associated with endothelial dysfunction and profound dysregulation of the thrombotic/fibrinolytic pathway. Defibrotide (DF) is a polyanionic compound with fibrinolytic, anti-thrombotic and anti-inflammatory properties.